Anti-Overingestion Abuse Deterrent Compositions
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 9,867,834 | Non-Systemic Topical Compositions Comprising Corticosteroids In force · High confidence | Patheon Softgels Inc. | In force | High confidence | ||
| US 9,877,971 | Soft Lozenges Comprising Corticosteroids In force · High confidence | Patheon Softgels Inc. | In force | High confidence | ||
| US 10,182,992 | Abuse-Deterrent Controlled Release Formulations In force · High confidence | Patheon Softgels Inc. | In force | High confidence | ||
| US 10,772,841 | Opioid Abuse-Deterrent Controlled Release Formulations In force · Medium confidence | Patheon Softgels Inc. | In force | Medium confidence | ||
| US 10,335,375 | Anti-Overingestion Abuse Deterrent Compositions In force · High confidence | Patheon Softgels Inc. | In force | High confidence | ||
| US 9,849,125 | Anti-Overingestion Dosage Forms Lapsed Dec 26, 2025 on the fee record Ended Dec 26, 2025 · High confidence | Patheon Softgels Inc. | Lapsed Dec 26, 2025 on the fee record | Ended Dec 26, 2025 | High confidence | |
| US 9,861,629 | Opioid Abuse Deterrent Dosage Forms Lapsed Jan 9, 2026 on the fee record Ended Jan 9, 2026 · High confidence | Patheon Softgels Inc. | Lapsed Jan 9, 2026 on the fee record | Ended Jan 9, 2026 | High confidence | |
| US 9,943,513 | Opioid Abuse Deterrent Dosage Forms Lapsed Apr 17, 2026 on the fee record Ended Apr 17, 2026 · High confidence | Patheon Softgels Inc. | Lapsed Apr 17, 2026 on the fee record | Ended Apr 17, 2026 | High confidence |
8 of 8 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
1 of these is in force and held by Banner Life Sciences LLC.
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.